ATE231851T1 - 6-o-alkyl erythronolid-b derivate - Google Patents

6-o-alkyl erythronolid-b derivate

Info

Publication number
ATE231851T1
ATE231851T1 AT98959480T AT98959480T ATE231851T1 AT E231851 T1 ATE231851 T1 AT E231851T1 AT 98959480 T AT98959480 T AT 98959480T AT 98959480 T AT98959480 T AT 98959480T AT E231851 T1 ATE231851 T1 AT E231851T1
Authority
AT
Austria
Prior art keywords
erythronolide
derivatives
alkyl
alkyl derivatives
erythromycin
Prior art date
Application number
AT98959480T
Other languages
English (en)
Inventor
Howard E Gracey
Stephen H Montgomery
David A Riley
Jih-Hua Liu
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of ATE231851T1 publication Critical patent/ATE231851T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
AT98959480T 1997-12-01 1998-11-17 6-o-alkyl erythronolid-b derivate ATE231851T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/980,919 US5919916A (en) 1997-12-01 1997-12-01 6-O-alkyl derivatives of erythronolide B
PCT/US1998/024497 WO1999028311A1 (en) 1997-12-01 1998-11-17 6-o-alkyl derivatives of erythronolide b

Publications (1)

Publication Number Publication Date
ATE231851T1 true ATE231851T1 (de) 2003-02-15

Family

ID=25527957

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98959480T ATE231851T1 (de) 1997-12-01 1998-11-17 6-o-alkyl erythronolid-b derivate

Country Status (13)

Country Link
US (1) US5919916A (de)
EP (1) EP1040107B1 (de)
JP (1) JP2001524549A (de)
KR (1) KR20010032636A (de)
AT (1) ATE231851T1 (de)
AU (1) AU1526899A (de)
CA (1) CA2309977A1 (de)
DE (1) DE69811120T2 (de)
DK (1) DK1040107T3 (de)
ES (1) ES2191982T3 (de)
IL (1) IL135792A0 (de)
PT (1) PT1040107E (de)
WO (1) WO1999028311A1 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100336447B1 (ko) * 1999-11-24 2002-05-15 민경윤 클라리스로마이신의 개선된 제조방법
US6565882B2 (en) 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
WO2001064224A1 (en) * 2000-02-29 2001-09-07 Teva Pharmaceutical Industries Ltd. Processes for preparing clarithromycin and clarithromycin intermediate, essentially oxime-free clarithromycin, and pharmaceutical composition comprising the same
DE60122791T2 (de) * 2000-03-15 2007-10-04 Hanmi Pharm. Co., Ltd. Verfahren zur Herstellung von Clarythromycin mit nicht pharmazeutischer Qualität
KR20000037126A (ko) * 2000-04-08 2000-07-05 김용규 6-메틸 에리스로마이신 ａ의 제조방법
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US6541014B2 (en) 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US6455680B1 (en) 2000-12-21 2002-09-24 Abbott Laboratories Methods utilizing aryl thioimines in synthesis of erythromycin derivatives
TWI246515B (en) 2001-05-30 2006-01-01 Abbott Lab An arylation method for the functionalization of O-allyl erythromycin derivatives
US7825200B2 (en) 2003-02-28 2010-11-02 The Regents Of The University Of California Controlled free radical grafting from polyolefins
US7601695B2 (en) * 2003-03-10 2009-10-13 Optimer Pharmaceuticals, Inc. Antibacterial agents
JP2006528185A (ja) 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
JP2006528190A (ja) 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
CA2533178C (en) 2003-07-21 2014-03-11 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
WO2005016311A1 (en) 2003-08-11 2005-02-24 Advancis Pharmaceutical Corporation Robust pellet
AU2004264356B2 (en) 2003-08-12 2011-01-27 Shionogi, Inc. Antibiotic product, use and formulation thereof
JP5686494B2 (ja) 2003-08-29 2015-03-18 シオノギ インコーポレイテッド 抗生物質製剤、その使用法及び作成方法
EP1663169A4 (de) 2003-09-15 2010-11-24 Middlebrook Pharmaceuticals In Antibiotisches produkt, seine verwendung und formulierung
WO2006014427A1 (en) 2004-07-02 2006-02-09 Advancis Pharmaceutical Corporation Tablet for pulsed delivery
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
AU2008316830B2 (en) 2007-10-25 2016-03-17 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
CN107854477A (zh) 2008-10-24 2018-03-30 森普拉制药公司 使用含三唑的大环内酯治疗抗性疾病的方法
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
US9480679B2 (en) 2009-09-10 2016-11-01 Cempra Pharmaceuticals, Inc. Methods for treating malaria, tuberculosis and MAC diseases
HRP20160168T1 (hr) 2010-03-22 2016-03-25 Cempra Pharmaceuticals Inc Kristalne forme makrolida i njihova uporaba
BR112012029586A2 (pt) 2010-05-20 2016-08-02 Cempra Pharmaceuticals Inc processos para preparar macrolídeos e cetolídeos e intermediários dos mesmos
KR20130120458A (ko) 2010-09-10 2013-11-04 셈프라 파마슈티컬스, 인크. 질환을 치료하기 위한 수소결합 형성 플루오로 케토라이드
WO2013148891A1 (en) 2012-03-27 2013-10-03 Cempra Pharmaceuticals, Inc. Parenteral formulations for administering macrolide antibiotics
WO2014152326A1 (en) 2013-03-14 2014-09-25 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
AU2014233240B2 (en) 2013-03-15 2018-08-09 Cempra Pharmaceuticals, Inc. Convergent processes for preparing macrolide antibacterial agents

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3697547A (en) * 1970-12-18 1972-10-10 Abbott Lab Erythronolide b derivatives
US4331803A (en) * 1980-06-04 1982-05-25 Taisho Pharmaceutical Co., Ltd. Novel erythromycin compounds
JPS5896097A (ja) * 1981-12-01 1983-06-07 Taisho Pharmaceut Co Ltd エリスロマイシンｂ誘導体
JPS60214796A (ja) * 1984-04-06 1985-10-28 Taisho Pharmaceut Co Ltd ６−０−メチルエリスロマイシン類の製法
JPS61103890A (ja) * 1984-10-26 1986-05-22 Taisho Pharmaceut Co Ltd ６−０−メチルエリスロマイシンａ誘導体
US4670549A (en) * 1985-03-18 1987-06-02 Taisho Pharmaceutical Co., Ltd. Method for selective methylation of erythromycin a derivatives
JPS61229895A (ja) * 1985-04-03 1986-10-14 Nippon Zeon Co Ltd 保護化デス−ｎ−メチルエリスロマイシン誘導体
DE3782994T2 (de) * 1986-09-18 1993-04-08 Taisho Pharma Co Ltd Erythromycin-a-derivate und verfahren zu ihrer herstellung.
JP2751385B2 (ja) * 1988-05-19 1998-05-18 大正製薬株式会社 エリスロマイシンａオキシム及びその塩の製造方法
US5141926A (en) * 1990-04-18 1992-08-25 Abbott Laboratories Erythromycin derivatives
JPH08149986A (ja) * 1994-09-28 1996-06-11 Taisho Pharmaceut Co Ltd １２−ヒドロキシ−６−ｏ−アルキルエリスロマイシン及びその類縁体の製造方法
US5756473A (en) * 1995-11-21 1998-05-26 Abbott Laboratories 6-O-methyl erythromycin D and process for making

Also Published As

Publication number Publication date
EP1040107B1 (de) 2003-01-29
US5919916A (en) 1999-07-06
AU1526899A (en) 1999-06-16
WO1999028311A1 (en) 1999-06-10
JP2001524549A (ja) 2001-12-04
EP1040107A1 (de) 2000-10-04
DE69811120T2 (de) 2003-10-09
IL135792A0 (en) 2001-05-20
PT1040107E (pt) 2003-06-30
KR20010032636A (ko) 2001-04-25
DK1040107T3 (da) 2003-05-05
ES2191982T3 (es) 2003-09-16
CA2309977A1 (en) 1999-06-10
DE69811120D1 (de) 2003-03-06

Similar Documents

Publication Publication Date Title
DE69811120D1 (de) 6-o-alkyl erythronolid-b derivate
ATE256138T1 (de) 9-oximsilyl erythromycin a derivate
FI931109L (fi) Peptider och nukleinsyrasekvenser, som haenfoer sig till epstein-barr-virus
NO904839D0 (no) Fremgangsmaate for fremstilling av benzoxazinderivater.
DE69709938D1 (de) N-benzylpiperidin- und tetrahydropyridin-derivate
NO872831L (no) FremgangsmŸte for fremstilling av nitrofuranderivater.
FI20040310A7 (fi) Menetelmä bentsosykloalkyyliatsolitionijohdannaisten valmistamiseksi
NO901070D0 (no) Fremgangsmaate for fremstilling av tieno-triazolo-diazepin-derivater.
NO924028L (no) Forbedret fremgangsmaate for fremstilling av substituerte indolonderivater
NO903780D0 (no) Fremgangsmaate til fremstilling av epipodofyllotoksinaltrosid-derivater.
NO901071D0 (no) Fremgangsmaate for fremstilling av tieno-triazolo-diazepin-derivater.
PT88158A (pt) Process for the preparation of a novel diosmin derivative
ATE196292T1 (de) Zwischenprodukte um 2-imidazolin-5onederivate herzustellen.
NO900969D0 (no) Fremgangsmaate for fremstilling av anilin-derivat.
NO874213D0 (no) Fremgangsmaate ved fremstilling av trombolyseblanding.
IS1853B (is) Ný aðferð til að búa til 3-N,N-dísýklóbútýlamínó-8-flúor-3,4-díhýdró-2H-1-bensópýran-5-karboxamíð
NO961429D0 (no) Fremgangsmåte for fremstilling av kinolonholdige, orale preparater
EE200000674A (et) Parendatud meetod farmatseutiliselt väärtuslike norbensomorfaaniderivaatide valmistamiseks
NO167387C (no) Fremgangsmaate for fremstilling av 2-guanidinothiazolderivat.
NO170578C (no) Fremgangsmaate for fremstilling n,n-dimetylaminometylarylforbindelser
FI20040505A7 (fi) Menetelmä 1,3-dihydro-6-hydroksi-2H-indol-2-oni-johdannaisten valmistamiseksi
NO881848D0 (no) Skjult innledning for frekvenshoppet synkronisering.
NO920207D0 (no) Fremgangsmaate for fremstilling av 6-methyl-oestra-4,6-diener
FI944968A7 (fi) Menetelmä sakkariinijohdannaisten valmistamiseksi
ES2019841A6 (es) Procedimiento para preparar derivados de tieno-triazolo-diazepina.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1040107

Country of ref document: EP

REN Ceased due to non-payment of the annual fee